Analysts Conflicted on These Healthcare Names: Cytokinetics (CYTK), Warby Parker (WRBY) and 89bio (ETNB)
A Quick Look at Today's Ratings for Warby Parker(WRBY.US), With a Forecast Between $25 to $32
Warby Parker Analyst Ratings
Warby Parker (WRBY) Receives a Hold From Morgan Stanley
Stifel Nicolaus Keeps Their Hold Rating on Warby Parker (WRBY)
A Quick Look at Today's Ratings for Warby Parker(WRBY.US), With a Forecast Between $23 to $30
Morgan Stanley Lifts Price Target on Warby Parker to $24 From $23, Keeps Equalweight Rating
Warby Parker Is Maintained at Outperform by Telsey Advisory Group
Analysts Are Bullish on These Healthcare Stocks: Silence Therapeutics (SLN), Warby Parker (WRBY)
Warby Parker Analyst Ratings
Telsey Advisory Group Maintains Outperform on Warby Parker, Maintains $28 Price Target
Roth MKM Maintains Warby Parker(WRBY.US) With Hold Rating, Maintains Target Price $26
BTIG Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $30
Roth MKM Initiates Warby Parker(WRBY.US) With Hold Rating, Announces Target Price $26
Piper Sandler Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $30
Telsey Advisory Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $28
BTIG Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $30
Warby Parker Price Target Maintained With a $28.00/Share by Telsey Advisory Group
Warby Parker Is Maintained at Outperform by Telsey Advisory Group
Warby Parker Analyst Ratings